Free Trial

Enhabit, Inc. (NYSE:EHAB) Shares Sold by Millennium Management LLC

Enhabit logo with Medical background

Millennium Management LLC reduced its position in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 27.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 610,000 shares of the company's stock after selling 233,005 shares during the period. Millennium Management LLC owned approximately 1.21% of Enhabit worth $4,764,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in EHAB. 8 Knots Management LLC increased its holdings in Enhabit by 16.4% in the fourth quarter. 8 Knots Management LLC now owns 4,430,898 shares of the company's stock valued at $34,605,000 after buying an additional 623,602 shares in the last quarter. D. E. Shaw & Co. Inc. increased its holdings in Enhabit by 33.2% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,004,215 shares of the company's stock valued at $7,843,000 after buying an additional 250,215 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Enhabit by 12.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,953,941 shares of the company's stock valued at $15,260,000 after buying an additional 213,774 shares in the last quarter. Paradice Investment Management LLC increased its holdings in Enhabit by 12.8% in the fourth quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company's stock valued at $13,903,000 after buying an additional 201,997 shares in the last quarter. Finally, Graham Capital Management L.P. purchased a new position in Enhabit in the fourth quarter valued at about $601,000.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reaffirmed a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.

Read Our Latest Analysis on EHAB

Enhabit Price Performance

Shares of EHAB stock traded down $0.15 during trading hours on Monday, hitting $10.35. The company's stock had a trading volume of 432,219 shares, compared to its average volume of 455,779. The business has a fifty day moving average of $8.86 and a 200-day moving average of $8.42. The stock has a market cap of $524.09 million, a price-to-earnings ratio of -4.46 and a beta of 1.61. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $10.79. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85.

Enhabit (NYSE:EHAB - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.07 by $0.03. The business had revenue of $259.90 million for the quarter, compared to analyst estimates of $266.11 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. As a group, equities research analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current year.

About Enhabit

(Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

See Also

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Should You Invest $1,000 in Enhabit Right Now?

Before you consider Enhabit, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.

While Enhabit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines